Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis

NCT02583152 is registered in ClinicalTrials.gov with Manchester Royal Eye Hospital as lead sponsor.

NCT NCT02583152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02583152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of New Imaging Technology to Assess Effect of Enzyme Replacment Therapy on Eye Disease Progession in Mucopolysacchardiosis
Lead sponsor
Manchester Royal Eye Hospital
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2015
Completion date
November 30, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucopolysaccharidoses